Humphrey Jeffrey 4
4 · Cyteir Therapeutics, Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
Humphrey Jeffrey
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-02-22+2,358→ 2,358 totalExercise: $5.96Exp: 2032-02-22→ Common Stock (2,358 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award vest in full on February 22, 2023, subject to the Reporting Person's continued service to the board of directors of the Company through the applicable vesting date.